AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol
Sign Up to like & getrecommendations! Published in 2017 at "BMJ Open"
DOI: 10.1136/bmjopen-2016-013636
Abstract: Introduction Sepsis is a leading global cause of morbidity and mortality, and is more common at the extremes of age. Moreover, the cost of in-hospital care for elderly patients with sepsis is significant. There are… read more here.
Keywords: sepsis; sepsis related; trial; aspirin inhibit ... See more keywords